CATHERINE BENSON: Open Payments
NPI 1548621824 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 48 payments from 27 companies in 2025. Trend: 2023 $1,622 · 2024 $385 · 2025 $2,243
Food & beverage: $1,163Consulting: $1,080
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $1,096 |
| Novartis Pharmaceuticals Corporation | 9 | $214 |
| JAZZ PHARMACEUTICALS INC. | 3 | $162 |
| AstraZeneca Pharmaceuticals LP | 4 | $109 |
| Janssen Biotech, Inc. | 2 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| ABBVIE INC. | 2 | $47 |
| Celgene Corporation | 2 | $41 |
| Aveo Pharmaceuticals, Inc. | 1 | $37 |
Products named: XTANDI, KISQALI, ZIIHERA, REBLOZYL, Nubeqa, ZEPZELCA, RYBREVANT, FOTIVDA.
Industry payments across TN — which companies pay providers there.
